Herbert Loong: Discussions on lung cancer screening policies in Asia-Pacific region at APCLC

Herbert Loong shared a post on X by Pankaj Kumar Panda, Clinical Researcher at National Cancer Centre Singapore, adding:

“Join us for detailed discussions on lung cancer screening policies in Asia Pacific region which are often unique given our different disease and molecular epidemiologies, healthcare systems, health infrastructure and heathcare accessibility and varying economies. Register today!”

Quoting Pankaj Kumar Panda’s post:

“Implementation of Lung Cancer screening is at diff stages across the Asia-Pacific region. Discussions about diversities in an upcoming webinar by Asia Pacific Coalition against Lung Cancer (APCLC) and Lung Cancer Policy Network.”

Sources: Herbert Loong/X and Pankaj Kumar Panda/X

More posts featuring Herbert Loong on oncodaily.com

Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network.

Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).